
AlayaCare
AlayaCare provides cloud-based software for home care agencies, integrating scheduling, billing, and analytics into its end-to-end AlayaCare Cloud platform.
Secondary Market Price
How AlayaCare Measures Up
To help you manage your AlayaCare equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of AlayaCare's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future AlayaCare Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for AlayaCare's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description
AlayaCare provides a cloud-based software platform for home-based care agencies. The company’s end-to-end software manages functions such as intake, scheduling, care management, billing, payroll, and data analytics. It serves a global customer base of over 700 organizations in the home care, home health, infusion, and palliative care sectors, facilitating more than 10 million patient visits per month. Information regarding the company's founding date, founders, and specific historical milestones is not detailed in the provided materials.
Looking forward, AlayaCare is focused on integrating artificial intelligence into its product offerings. The company recently announced Layla, an AI assistant for workflows, and AlayaFlow, a set of AI agents intended to improve operational efficiency. AlayaCare has invested $250 million in research and development, signaling a continued emphasis on technological innovation, particularly in applying AI to home-based care workflows and predictive analytics.
- inovia capital
- Chrysalis
- Fonds Innovexport
- Caisse de dépôt et placement du Québec
- Investissement Québec
- Desjardins – Innovatech
- Generation Investment Management
- Co-Founder, Adrian Schauer
- Co-Founder, Brady Murphy
- Co-Founder, Neil Grunberg
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is AlayaCare worth joining?
Deciding whether to join AlayaCare is a personal choice that depends on your career goals and the overall compensation package. If your offer includes equity, tools like Prospect can help you model its potential future value to make a more informed decision.
What should I do with my AlayaCare stock?
The right strategy for your AlayaCare stock depends on your personal financial goals and risk tolerance. Platforms like Prospect offer personalized option exercise strategies and tax optimization to help you maximize your equity's value.
Can you sell AlayaCare stock?
Selling stock in a private company like AlayaCare is often possible through secondary markets or company-organized tender offers. To navigate this process, Prospect provides tender offer tools that help you decide how much to sell and which shares are the most tax-efficient.
How can I find the value of my AlayaCare stock?
The value of private stock is typically determined by 409A valuations and recent funding rounds, but these can be infrequent. For a more dynamic forecast, Prospect uses predictive models trained on proprietary data to project your stock's potential future value.
What is AlayaCare's equity worth?
The precise worth of your AlayaCare equity is not public, but you can estimate its potential value based on company performance and market data. Tools from Prospect can help you model different scenarios and understand the potential post-tax value of your holdings.
What is AlayaCare's stock ticker symbol?
As a privately held company, AlayaCare does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell AlayaCare stock?
Buying shares in a private company like AlayaCare is typically restricted to accredited investors or employees, while selling is often possible during tender offers or on secondary markets. If you are considering selling, Prospect offers tools to help you optimize the sale for the best possible tax outcome.
What is the criteria to buy or invest in AlayaCare stock?
Investing in a private company like AlayaCare is generally limited to employees receiving equity compensation or accredited investors who meet specific financial criteria. These criteria, such as minimum income or net worth, are defined by financial regulators.

